StemRIM (TYO:4599)
Japan · Delayed Price · Currency is JPY 303.00
+1.00 (0.33%)
Aug 6, 2026, 11:30 AM JST
StemRIM Market Cap
StemRIM has a market cap or net worth of 18.93 billion as of August 5, 2026. Its market cap has decreased by -7.40% in one year.
Market Cap
18.93B
Enterprise Value
13.22B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
303.00
ChartMarket Cap Chart
Since August 9, 2019, StemRIM's market cap has decreased from 49.82B to 18.93B, a decrease of -62.00%. That is a compound annual growth rate of -12.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 18.93B | 14.83% |
| Dec 30, 2025 | 16.49B | -15.37% |
| Dec 30, 2024 | 19.48B | -45.16% |
| Dec 29, 2023 | 35.52B | -34.08% |
| Dec 30, 2022 | 53.89B | 3.59% |
| Dec 30, 2021 | 52.02B | 40.86% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Heartseed | 39.53B |
| Cuorips | 39.10B |
| Healios K.K. | 32.40B |
| Japan Tissue Engineering | 31.76B |
| Renascience | 20.83B |
| AnGes | 19.54B |
| CanBas | 14.12B |
| RaQualia Pharma | 12.70B |